EFFICIENCY OF THE PROLONGED THERAPY BY THE ANTISECRETORY MEDICATIONS IN THE REDUCTION OF THE POSTHELICOBACTERIAL GASTRITIS RISKS AMONG THE CHILDREN

The authors studied the efficiency of the 3 months long therapy by Rabeprazole after eradication of the causative agent in the children with h. pylori associated gastritis from the high risk group of the development post helicobacter gastritis. They demonstrated that most children with h. pylori ass...

Full description

Saved in:
Bibliographic Details
Main Authors: E.A. Potrakhova (Author), N.V. Sobotyuk (Author), A.V. Kononov (Author)
Format: Book
Published: Union of pediatricians of Russia, 2008-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7cd431e16bd545e79b6d1cb6c1e5666d
042 |a dc 
100 1 0 |a E.A. Potrakhova  |e author 
700 1 0 |a N.V. Sobotyuk  |e author 
700 1 0 |a A.V. Kononov  |e author 
245 0 0 |a EFFICIENCY OF THE PROLONGED THERAPY BY THE ANTISECRETORY MEDICATIONS IN THE REDUCTION OF THE POSTHELICOBACTERIAL GASTRITIS RISKS AMONG THE CHILDREN 
260 |b Union of pediatricians of Russia,   |c 2008-09-01T00:00:00Z. 
500 |a 1727-5776 
500 |a 2500-3089 
520 |a The authors studied the efficiency of the 3 months long therapy by Rabeprazole after eradication of the causative agent in the children with h. pylori associated gastritis from the high risk group of the development post helicobacter gastritis. They demonstrated that most children with h. pylori associated gastritis, who have un favourable prognostic factors, have persistence of the inflammatory infiltrate in the mucosa of the antral stomach after eradication, which is accompanied with the elevated secretion of the hydrochloric acid and development of the acid dependent diseases. The use of the anti secretory medications during 3 months after h. pylori eradication among these children allows one to prevent the development of the gastritis and its complications.Key words: h. pylori_associated gastritis, eradication of h. Pylori, children, rabeprazole. 
546 |a RU 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Педиатрическая фармакология, Vol 5, Iss 5, Pp 38-42 (2008) 
787 0 |n https://pf.spr-journal.ru/jour/article/view/773 
787 0 |n https://doaj.org/toc/1727-5776 
787 0 |n https://doaj.org/toc/2500-3089 
856 4 1 |u https://doaj.org/article/7cd431e16bd545e79b6d1cb6c1e5666d  |z Connect to this object online.